LXRX Earnings — Lexicon Pharmaceuticals, Inc. Post-ER Performance | BigEarnings
LXRX — Lexicon Pharmaceuticals, Inc.
XNAS · Healthcare · Biotechnology
Price$2.18
Market Cap$968.3M
P/E—
52W Range$0.61 – $2.53
Next Earnings2026-08-05
About Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
